Beyond Bile Acids: Targeting Farnesoid X Receptor (FXR) with Natural and Synthetic Ligands

被引:46
|
作者
Carotti, Andrea [1 ]
Marinozzi, Maura [1 ]
Custodi, Chiara [1 ]
Cerra, Bruno [1 ]
Pellicciari, Roberto [1 ,2 ]
Gioiello, Antimo [1 ]
Macchiarulo, Antonio [1 ]
机构
[1] Univ Perugia, Dipartimento Sci Farmaceut, I-06123 Perugia, Italy
[2] TES Pharma Srl, I-06073 Corciano, Perugia, Italy
关键词
Bile acid homeostasis; Farnesoid X receptor; Natural ligands; Nuclear receptors; Synthetic ligands; SPONGE THEONELLA-SWINHOEI; CHOLESTEROL-RAISING FACTOR; ORPHAN NUCLEAR RECEPTOR; SALT EXPORT PUMP; MARINE SPONGE; BIOLOGICAL EVALUATION; ACTIVATED RECEPTOR; SULFATED POLYHYDROXYSTEROIDS; SCHISANDRA-GLAUCESCENS; CELL-PROLIFERATION;
D O I
10.2174/1568026614666141112094058
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The modulation of FXR receptor remains an attractive area in drug discovery to develop novel therapeutic opportunities for liver and metabolic disorders. Despite the large variety of FXR ligands reported so far, only a very restricted number of agonists have entered in clinical settings. In this review article we provide the reader with an overview on the different classes of natural and synthetic ligands that have been developed by academic groups and pharmaceutical companies to target FXR. We discuss their structure-activity relationships, analyzing the binding modes that some of these compounds adopt to interact with the receptor.
引用
收藏
页码:2129 / 2142
页数:14
相关论文
共 50 条
  • [1] Farnesoid X receptor (FXR): Structures and ligands
    Jiang, Longying
    Zhang, Huajun
    Xiao, Desheng
    Wei, Hudie
    Chen, Yongheng
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 : 2148 - 2159
  • [2] The farnesoid X receptor (FXR) as modulator of bile acid metabolism
    Kuipers, F
    Claudel, T
    Sturm, E
    Staels, B
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2004, 5 (04): : 319 - 326
  • [3] The Farnesoid X Receptor (FXR) as Modulator of Bile Acid Metabolism
    Folkert Kuipers
    Thierry Claudel
    Ekkehard Sturm
    Bart Staels
    Reviews in Endocrine and Metabolic Disorders, 2004, 5 : 319 - 326
  • [4] Identification of intermediates in the bile acid synthetic pathway as ligands for the farnesoid X receptor
    Nishimaki-Mogami, T
    Une, M
    Fujino, T
    Sato, Y
    Tamehiro, N
    Kawahara, Y
    Shudo, K
    Inoue, K
    JOURNAL OF LIPID RESEARCH, 2004, 45 (08) : 1538 - 1545
  • [5] Regulation of the farnesoid X receptor (FXR) by bile acid flux in rabbits
    Xu, GR
    Pan, LX
    Li, H
    Forman, BM
    Erickson, SK
    Shefer, S
    Bollineni, J
    Batta, AK
    Christie, J
    Wang, TH
    Michel, J
    Yang, S
    Tsai, R
    Lai, L
    Shimada, K
    Tint, GS
    Salen, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (52) : 50491 - 50496
  • [6] Anthranilic acid derivatives as novel ligands for farnesoid X receptor (FXR)
    Merk, Daniel
    Gabler, Matthias
    Gomez, Roberto Carrasco
    Flesch, Daniel
    Hanke, Thomas
    Kaiser, Astrid
    Lamers, Christina
    Werz, Oliver
    Schneider, Gisbert
    Schubert-Zsilavecz, Manfred
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (08) : 2447 - 2460
  • [7] Inhibitory Effects of Bile Acids and Synthetic Farnesoid X Receptor Agonists on Rotavirus Replication
    Kim, Yunjeong
    Chang, Kyeong-Ok
    JOURNAL OF VIROLOGY, 2011, 85 (23) : 12570 - 12577
  • [8] Bile Acids and Farnesoid X Receptor in Renal Pathophysiology
    Yang, Jiufang
    Pontoglio, Marco
    Terzi, Fabiola
    NEPHRON, 2024, 148 (09) : 618 - 630
  • [9] Endogenous bile acids are ligands for the nuclear receptor FXR BAR
    Wang, HB
    Chen, J
    Hollister, K
    Sowers, LC
    Forman, BM
    MOLECULAR CELL, 1999, 3 (05) : 543 - 553
  • [10] Bile Diversion Improves Metabolic Phenotype Dependent on Farnesoid X Receptor (FXR)
    Pierre, Joseph F.
    Li, Yuxin
    Gomes, Charles K.
    Rao, Prahlad
    Chang, Eugene B.
    Yin, Deng Ping
    OBESITY, 2019, 27 (05) : 803 - 812